Shockwave Medical's receivables is $120M.
Get informed when a big investor buys or sells
+ FollowLatest change versus the prior comparable period (same company).
Shockwave Medical (SWAV) currently reports a receivables of $120M as of March 2024. That compares with $84M in the prior-year period — up 47.6% year over year. Use the charts on this page to explore Shockwave Medical's receivables history and peer comparisons.
Shockwave Medical's receivables increased from $84M to $120M — a 47.6% year-over-year increase (period ending March 2024). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.
Shockwave Medical reported $120M in receivables as of March 2024. That compares with $84M in the prior-year period — up 47.6% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.
Start with the current receivables of $120M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Shockwave Medical, and consider following SWAV for alerts when major investors trade the stock.
Shockwave Medical is classified in the Healthcare sector. On receivables, it currently shows $120M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing SWAV with unrelated industries.